Wanbang Biopharmaceuticals

Wanbang Biopharmaceuticals is a Manufacturer/Innovator company operating in the pharmaceutical industry.

Wanbang Biopharmaceuticals focuses on developing, manufacturing, and selling pharmaceuticals for patients of diabetes and related cardiovascular diseases. Its products include animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium.

Company type

Manufacturer/Innovator

Products and services

Pharmaceutical Products / ATC coding, Biopharmaceuticals

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address

Wanbang Biopharmaceuticals, South of Dongshan,, Comprehensive Area,, Xuzhou/Jiangsu, China, 221004